Skip to content

Psychedelics and cognitive liberty: Reimagining drug policy through the prism of human rights.

C. Walsh

The International journal on drug policy March 1, 2016 DOI: 10.1016/j.drugpo.2015.12.025 via Semantic Scholar

Summary

AI-generated from the abstract

Drug prohibition in the UK, particularly for psychedelics, violates the fundamental right to cognitive liberty protected by Article 9 of the European Convention on Human Rights. The paper argues that existing challenges to prohibition based on therapeutic or religious exemptions are insufficient; instead, the right to control one's own consciousness should ground a complete end to psychedelic prohibitions. This legal argument is supported by classical liberal philosophy: the state should only criminalize actions that demonstrably risk harming others. The authors recommend that drug policy activism move beyond harm reduction toward benefit maximization and consider a regulatory "third way" distinct from criminal or medical control. However, given the UK's authoritarian turn, underground movements may be the only near-term guarantor of cognitive liberty.

Study at a glance

Characteristics Theoretical or philosophical paper Peer reviewed
Keywords Sociology Medicine Law Philosophy Political science
Citations 37
Key finding Psychedelic drug prohibition in the UK breaches the right to cognitive liberty under Article 9 of the ECHR, and this right, combined with classical liberal harm principles, justifies ending such prohibitions.

Abstract

This paper reimagines drug policy--specifically psychedelic drug policy--through the prism of human rights. Challenges to the incumbent prohibitionist paradigm that have been brought from this perspective to date--namely by calling for exemptions from criminalisation on therapeutic or religious grounds--are considered, before the assertion is made that there is a need to go beyond such reified constructs, calling for an end to psychedelic drug prohibitions on the basis of the more fundamental right to cognitive liberty. This central concept is explicated, asserted as being a crucial component of freedom of thought, as enshrined within Article 9 of the European Convention on Human Rights (ECHR). It is argued that the right to cognitive liberty is routinely breached by the existence of the system of drug prohibition in the United Kingdom (UK), as encoded within the Misuse of Drugs Act 1971 (MDA). On this basis, it is proposed that Article 9 could be wielded to challenge the prohibitive system in the courts. This legal argument is supported by a parallel and entwined argument grounded in the political philosophy of classical liberalism: namely, that the state should only deploy the criminal law where an individual's actions demonstrably run a high risk of causing harm to others. Beyond the courts, it is recommended that this liberal, rights-based approach also inform psychedelic drug policy activism, moving past the current predominant focus on harm reduction, towards a prioritization of benefit maximization. How this might translate in to a different regulatory model for psychedelic drugs, a third way, distinct from the traditional criminal and medical systems of control, is tentatively considered. However, given the dominant political climate in the UK--with its move away from rights and towards a more authoritarian drug policy--the possibility that it is only through underground movements that cognitive liberty will be assured in the foreseeable future is contemplated.

Comments

No comments yet.

Log in to comment